• TempraMed signed an exclusive distribution agreement with SPORTORO on October 19, 2026, for Croatia, Serbia and Bosnia and Herzegovina.
• The three-year agreement covers VIVI Cap, VIVI Epi and VIVI Med medication-protection products.
• Minimum purchase targets total approximately USD 550,000 over the term, assuming an all-VIVI Cap product mix at current prices.
• An initial order is due and payable upon signing; a second order is targeted within six months of the first.
• Exclusivity depends on performance conditions; SPORTORO is responsible for obtaining country-specific regulatory approvals at its expense.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempramed Technologies Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610280305NEWSFILECNPR____20261028_321298_1) on October 28, 2026, and is solely responsible for the information contained therein.